IP Library › Granted Patent US 9,290,569
Granted Patent B2
US 9,290,569 · App. 13/019,557 · Granted Mar 22, 2016

Anti FGF23 antibody and a pharmaceutical composition comprising the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,290,569
App. No.
13/019,557
Granted
Mar 22, 2016
Kind
B2
Abstract

To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).

Claims (3)

1. An antibody or functional fragment thereof that binds to FGF23, wherein the antibody or functional fragment comprises a heavy and light chain,

said heavy chain comprises CDR1 shown by SEQ ID NO: 40, CDR2 shown by SEQ ID NO: 41, and CDR3 shown by SEQ ID NO: 42, and

said light chain comprises CDR1 shown by SEQ ID NO: 43, CDR2 shown by SEQ ID NO: 44, and CDR3 shown by SEQ ID NO: 45.

Assignments (1)
CHANGE OF NAME Recorded Oct 21, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050777/0905 →